MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$3,999K Restricted cash securitydeposit$50K Prepaid expenses andother current assets$26K In-process research anddevelopment$2,260K Operating leaseright-of-use assets - net$531K Restricted cash - securitydeposit$200K Leasehold improvementsand equipment - net$138K Finance leaseright-of-use assets - net$4K Total current assets$4,075K Total non-currentassets$3,133K Total assets$7,208K Total liabilities andstockholders equity$7,208K Total stockholdersequity$4,830K Total liabilities$2,378K Accumulated deficit-$210,787K Additional paid-in capital$215,616K Total currentliabilities$1,463K Total non-currentliabilities$915K Common stock par value0.0001 per share,...$1K Operating leaseliabilities - current$694K Accrued expenses andother liabilities$452K Accounts payable$315K Financing leaseliabilities - current$2K Operating leaseliabilities - net of current...$653K Deferred tax liability$257K Financing leaseliabilities - net of current...$5K
Balance Sheet
source: myfinsight.com

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Holdings, Inc. (MTNB)